During the course of our investigations of newanthracycline producers, we obtained several unique blocked mutants from Streptomyces violaceus A262 which is known to produce /?-rhodomycinone glycosides, A262-1, A262-2 and A262-31}. One of the variant strains isolated was found to produce four /?-isorhodomycinone glycosides (obelmycins A, B, C and D) and three y-isorhodomycinone glycosides (obelmycins E, F and G)2). Anthracycline antibiotics belonging to the /?-rhodomycin and y-rhodomycin class have been isolated by several groups3'40. However, there are few reports concerning /?-isorhodomycins and y-isorhodomycins. Brockmann and Patt isolated /?-isorhodomycin II in 19555) and /?-isorhodomycin S-la in 19756), and recently 1-hydroxycytorhodins were disclosed in 19867). This paper describes newanthracycline antibiotic obelmycins which are produced by a variant strain ofS. violaceus A262. Obelmycins B and C were identical to 1-hydroxycytorhodins A and N7), respectively.
Materials and Methods

Microorganisms
The obelmycin-producing strain SE2-2385 was isolated from S. violaceus A262 as previously described1*, cultivated at 28°C on YS agar slant (yeast extract 0.3%, soluble starch 1.0% and agar 1.5%, pH 7.2) and then stored at 5°C. This strain was deposited as FERMP-8165 in Fermentation Research Institute, Agency of Industrial Science and Technology.
Fermentation
A seed culture was grown aerobically at 28°C for 48 hours in a 500-ml Erlenmeyer flasks containing Present address: * Showa Pharmacochemical Co., Ltd., 1-16-5, Kyobashi, Chuo-ku, Tokyo 104, Japan. n Faculty of Applied Biological Science, Hiroshima University, 1-4-4 Kagamiyama, Higashihiroshima 724, Japan. ZnSO4-7H2O 0.0032g, MnCl2-4H2O 0.013g per 1,000ml of tap water, pH 7.0. Conditions used were 15 liters/minute for aeration and 300 rpm for agitation. Cultivation was carried out at 28°C for 130 hours at which time the mycelial purple pigments were produced at approximately maximumlevel. About 30 liters of the culture broth was used for the isolation of purified obelmycins.
Biological Activity
In vitro cytotoxicitiy and inhibition of DNAand RNAsyntheses against a cell culture of murine leukemia L1210 were assayed according to the method as previously described8). Antimicrobial activity was assayed by the standard broth dilution method1.
Qualitative Determination of Aglycone and Sugars by TLC Obelmycin in 0.1 n HC1(lOmg/ml) was heated at 85°C for 30 minutes in a water bath. The aglycone, thus obtained, was extracted with CHC13.The CHC13layer was evaporated in vacuo to dryness and the purple pigment residue was then purified by preparative TLC on Silica gel plate PF254 (E. Merck) using a developing solvent of CHC13-MeOH(20 : 1). Purified aglycone was subjected to TLC on Silica gel F254 (E. Merck) using a developing solvent of CHC13 -MeOH (20 : 1).
Alternatively, the aqueous layer containing sugar components was neutralized by addition of silver carbonate with a small amount of charcoal and centrifuged. The supernatant fluid was concentrated in vacuo and subjected to TLC on Silica gel plate F254 (E. Merck) using a developing solvent of BuOH-acetic acid-H2O (4: 1 : 1). Sugars were detected by spraying with /?-anisaldehyde-H2SO4
(each 5%) in 90% EtOHand heating at 90°C. Aclarubicin and MA144-N19)were also hydrolyzed under the same conditions and the aqueous layers were used as a source of authentic sugars including L-rhodosamine (RN), 2-deoxy-L-fucose (dF), L-rhodinose (R) and L-cinerulose A (CinA); Rf values were 0.12, 0.56, 0.71 and 0.82, respectively.
Total Acid Hydrolysis of Obelmycin D Obelmycin D (40mg) was hydrolyzed under the same conditions described above. After extraction with CHC13, the hydrolysate was passed through a Dowex 50W ion exchange resin and eluted with 1 n HC1. The eluate containing rhodosamine (adjusted to pH 6.0 with Diaion WA-20) was evaporated to dryness in vacuo and chromatographed on a column of silica gel (Wakogel C-200) using a solvent mixture of CHC13-MeOH(10 : 1~3 : 1). Alternatively, the effluent containing rhodinose and 2-deoxyfucose was treated similarly, however, it was chromatographed on a column of silica gel using a solvent mixture of CHCl3-MeOH (50: 1-10:1).
Mild Acid Hydrolysis
Partial hydrolysis of obelmycin (1 mg/ml of 0.1 n HC1) was carried out as follows. Obelmycin in solution was held at room temperature for 1 hour. After adjusting the pH to 8.0 with 0.1 n NaOH, the hydrolysate was extracted with CHC13and the organic layer was evaporated to dryness in vacuo. The purple pigment residue was then subjected to TLC on Silica gel plate F254 using a developing solvent of CHC13-MeOH-aq NH3 (80: 10: 1).
Hydrogenolysis
Obelmycin in MeOH(10mg/ml) was hydrogenated over a double weight of 5% Pd-BaSO4 at room temperature and atmospheric pressure for 2 hours. An equal volume of H2Owas added, the products were extracted with CHC13and evaporated to dryness in vacuo. The purple pigment residue was subjected to TLC on Silica gel F254 using a developing solvent of CHC13 -MeOH (15 : 1). OCT. 1991 Purity of the products was determined by HPLCusing a Hitachi 655 liquid chromatographic apparatus with a reverse phase analytical column, A312 (ODS) (6 x 150mm) (Yamamura Chemical Laboratories Co., Ltd.). Acetonitrile-water (35 : 65) (adjusted to pH 2.0 with H3PO4) was used as the mobile phase and was run at a flow rate of 1.0ml/minute. Samples were dissolved in the mobile phase and 10(A of samples were injected. Detection was performed at 254nm using a UV detector (UVILOG-5IIIA, Oyo-Bunko Kiki Co., Ltd.). General MP's were determined on a Kofler hotstage microscope. UVspectra were carried out on a Hitachi EPS 3T and IR spectra (KBr pellet) on a Hitachi EPI-GS spectrophotometer.
XHand 13C NMRwere recorded with a Jeol GX-400 spectrometer at 400MHzand 100MHz,respectively. Chemical shifts are expressed in S values (ppm) with TMSas an internal reference and coupling constants are given in / (Hz). Mass spectra were recorded with a Hitachi M-80Hspectrometer. Specific rotations were determined on a Jasco DIP-181 Digital Polarimeter.
Results
Isolation and Purification of Obelmycins
The fermentation broth (30 liters) was filtered and the anthracycline products were extracted from the mycelial cake with a total of 10 liters of acetone. The acetone extract was evaporated to about 2 liters in vacuo. The concentrate (pH 8.0) was extracted with CHC13and the CHC13layer was evaporated to a small volumein vacuo. Anexcess of rc-hexane wasadded to precipitate the crude mixture of anthracycline products. The yield was about 9.4 g ofa purple crude powder which contained some seven violet components as observed on silica gel TLC (CHC13-MeOH-aq NH3(80: 10: 1)). The powder was chromatographed on a silica gel column which was developed successively with CHCl3-MeOH(100: 1, 100:2, 100: 5 and 100 : 10 mixtures) to elute obelmycins E, F, B, C, D, G and A in that order. Each compound was further purified by preparative TLC using a mixture of CHC13-MeOH-aq NH3(100 : 10 : 1 for obelmycins B, C, D, E and F, and 100: 18:2 for A and G). Each obelmycin band was scraped from the TLC plate and extracted with CHC13-MeOH(7 : 1). The extract was evaporated to dryness; the residue was dissolved in 0.1 m acetate buffer (pH 3.5) and washed with toluene. The aqueous layer was adjusted to pH 7.5 by addition of saturated aqueous NaHCO3and extracted with CHC13. The CHC13layer was washed with H2O, dried over Na2SO4and concentrated. An excess of rc-hexane was added to precipitate the respective obelmycin. The purified obelmycins A, B, C, D, E, F and G yielded 18mg, 126mg, 73mg, 82mg, 18mg, 12mg and 10mg, respectively. The purity of these compounds was determined to be greater than 95% as determined by HPLC. Obelmycins A, B, C, D, E, F and G had Rt's of3.8, 3.6, 2.9, 2. the presence of hydrogen bonded carbonyl (1600cm x) which is characteristic of anthracyclines. The molecular formulas were determined by mass spectra. On total acid hydrolysis obelmycins gave two kinds of purple aglycones and some sugar components. The aglycone of obelmycins A, B, C and D was found to be /?-isorhodomycinone by direct comparison with an authentic sample on TLC using CHCl3-MeOH(20: 1) (Rf value: 0.36, Table 2 ) and its identity was established by mass spectrum (m/z 402 M+) with a molecular formula of C20H18O9and *£! and 13C NMRspectra1*. Similarly the aglycone of obelmycins E, F and G was identified as y-isorhodomycinone by mass spectrum (m/z 387 (M+H)+ with a molecular formula of C20H18O8and XHand 13C NMR spectra1\
The sugar components were determined by comparison with authentic samples (prepared from aclacinomycins) and the resuls are shown in Table 2 together with obelmycin A (7-0-rhodosaminyl-/?-isorhodomycinone) with a molecular formula of C^H^O^N {m/z 559 M+), while obelmycins E and F gave G (10-0-rhodosaminyl-yisorhodomycinone) with a molecular formula of C28H33O10N(m/z 543 M+). On hydrogenolysis obelmycins B and C gave obelmycin E as a result of a reductive deglycosidation at C-7, and D gave F similarly, indicating that the sugar chains attached at C-10 were the same with respect to obelmycins B, C and E. Similarly, the same was true in the case ofD and F. Obelmycin A gave an aglycone, y-isorhodomycinone. Sugar moeity attached to C-7: Obelmycins R x R2
The chemical shift assignments of XH and 13C NMRspectra of obelmycins were carried out by means of the pulse technique, DEPT,^^H and -^C COSY, and are shown in Tables 3 and 4 From all these findings the structures of obelmycins were determined as illustrated in Fig. 1 . The structure of obelmycin A was further confirmed by 1H detected heteronuclear multiple-bond connectivity (HMBC)experiment and the long range couplings detected are shown in Fig. 2 . The long range couplings In the inhibition test for nucleic acid synthesis, the drugs were exposed for 60 minutes to L1210 cell culture (8 x 105 cells/ml) with supplemented 14C-labeled uridine or thymidine (0.05 juCi/ml), and the incorporation of the radioisotopes into acid insoluble material was measured. For the growth inhibition test, the drugs were exposed for 48 hours to L1210 cell culture (5 x 104 cells/ml) and the viable cells were counted by coulter counter.
IC50 is expressed as a drug concentration required to inhibit by a 50% control of the growth, and DNAand RNAsyntheses of cultured L1210 cells.
Abbreviations:
OBM: Obelmycin, COM: cosmomycin. observed between 7-H and C-l', and l'-H and C-7 proved its sugar linkage at C-7.
Biological Activity Antimicrobial activities of obelmycins are shown in Table 5 . All obelmycins exhibited antimicrobial activity against all of the Gram-positive and Gram-negative bacteria tested and weak activity against Candida albicans. Obelmycin B was the most active amongthe obelmycins tested and proved to be more active than A447C (1-deoxyobelmycin B) with the same sugar chain. Obelmycin A was also more active than /?-rhodomycin I (1-deoxyobelmycin A) . These results suggest that a hydroxyl group at C-l plays an important role in the antimicrobial activity. y-Isorhodomycinone glycosides (obelmycins E and G) were less active than /Msorhodomycinone glycosides (obelmycins A and B).
The activities of obelmycins and related compoundsagainst cultured L1210 cells were examined and the results are shown in Table 6 . Obelmycins A, B, C and D had very potent cytotoxic activity in comparison with the anthracyclines, aclarubicin and doxorubicin, which are used therapeutically. A comparison of the cytotoxicity of related compounds showed that the presence of a hydroxyl group at C-l and sugar at C-7 is also important for the cytotoxicity exhibited against L1210 cells. As noted with aclarubicin, obelmycins A, B, C and D inhibited RNAsynthesis more strongly than DNAsynthesis whereas obelmycins E, F, and G without glycosidic sugar at C-7 inhibited both syntheses to a similar extent.
Antitumor effects in vivo of obelmycins on mice bearing leukemia L1210 were tested by daily ip administration from day 1 to 10. Obelmycins A, B and E exhibited a maximumantitumor activity of 155, 120 and 108% (T/C) at an optimum dose of 100, 3.1 and 12.5)Ug/mouse/day, respectively.
Discussion
Wedescribe here the chemical and biological properties of new anthracycline antibiotics, obelmycins, produced by a variant strain SE2-2385 of S. violaceus A262. Obelmycins A, B, C and D were shown to be /?-isorhodomycinone glycosides with sugar chains at C-7 and C-10 while obelmycins E, F and G were y-isorhodomycinone glycosides with a sugar chain at C-10. Ordinarily, it is difficult to separate small quantities of isorhodomycins from their counterpart compounds,^-rhodomycins, but we could readily isolate them. This was attributable to the high yields of isorhodomycins synthesized by the mutant strain SE2-2385 which was effective in oxidation at the C-l position. By structural analysis it was found that obelmycins A, B, C, D, E, F and G were 1-hydroxy analogs of /?-rhodomycin I, A447 D13), cosmomycin C14), cosmomycin D14), cosmomycin A15), cosmomycin B15) and iremycin16), respectively. This relationship is similar to that observed between cinerubins and aclacinomycins1 7).
Biological activities of obelmycins were compared with those of some 1-deoxyobelmycins and the obelmycins were found to be more active than the 1-deoxyobelmycins. This suggests that a hydroxyl group at C-l may play an important role in the cytotoxic activity of the compounds. Obelmycins B, C and D, diglycosidic anthracyclines, were more cytotoxic in comparison with monoglycosidic anthracyclines such as obelmycin A and betaclamycin A1 8), however their antitumor activities in vivo were not always as striking.
